John F. Sandbach

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735

Stephen E. Jones, Frankie A. Holmes, Joyce O’Shaughnessy et al. · Journal of Clinical Oncology · 2009 · 586 citations

Medicine, Oncology, Pharmacology +11

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer

Stephen E. Jones, Michael A. Savin, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2006 · 540 citations · Full text

Medicine, Oncology, Pharmacology +17

A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genes

Saundra S. Buys, John F. Sandbach, Amanda Gammon et al. · Cancer · 2017 · 409 citations · Full text

Medicine, Genetics, Oncology +17

Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy

Daniel D. Von Hoff, James T. Casper, Edward C. Bradley et al. · The American Journal of Medicine · 1981 · 370 citations

Medicine, Cancer Biology, Oncology +9

Prospective clinical trial of a human tumor cloning system.

Daniel D. Von Hoff, Gary M. Clark, Brian J. Stogdill et al. · PubMed · 1983 · 339 citations

Medicine, Oncology, Pharmacology +15